ModeRNA statistics

info info

Citations per year


Popular tool citations

chevron_left 3D structure prediction chevron_right

Tool usage distribution map

Tool usage distribution map
info info

Associated diseases

Associated diseases
Want to access the full stats & trends on this tool?

ModeRNA specifications


Unique identifier OMICS_04465
Name ModeRNA
Interface Web user interface
Restrictions to use None
Computer skills Basic
Stability Stable
Maintained Yes


  • person_outline Janusz Bujnicki <>

Publication for ModeRNA

ModeRNA citations


Randomized dose escalation trial of elamipretide in adults with primary mitochondrial myopathy

PMCID: 5890606
PMID: 29500292
DOI: 10.1212/WNL.0000000000005255

[…] data in pediatric patients with hunter syndrome and cognitive impairment who are receiving intrathecal idursulfase-it and iv elaprase? ert. (pi: gerard vockley) 10/11/16 - 10/10/18 0.12 cal. months moderna tx, inc. $195,491 mcad study this agreement pursue studies with therapeutic rnas for genetic disorders of fatty acid oxidation. our lab will perform all animal studies and the necessary […]


Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections

PMCID: 5908250
PMID: 29590614
DOI: 10.1016/j.celrep.2018.03.001

[…] with the other authors contributing to editing into the final form., declaration of interests , m.s.d. is a consultant for inbios, aviana, and sanofi and on the scientific advisory board of moderna., oral antibiotics increase susceptibility of mice to severe flavivirus disease, oral antibiotics impair development of optimal antiviral t cell responses, oral antibiotics alter bacterial […]


Novel Platforms for the Development of a Universal Influenza Vaccine

PMCID: 5877485
PMID: 29628926
DOI: 10.3389/fimmu.2018.00600

[…] the immunogenicity of various mrna vaccines (, ). preclinical and clinical studies suggest that non-amplifying mrna vaccines are effective in mice, non-human primates and humans (, ). recently, moderna therapeutics published the results of a phase 1 clinical trial study of a modified mrna vaccine encoding ha protein of avian h10n8 formulated in lipid nanoparticles (lnps) and demonstrated […]


Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus

PMCID: 5829823
PMID: 29487230
DOI: 10.1128/mBio.00008-18

[…] participated in editing the final version of the manuscript., as potential conflicts of interest, m.s.d. is a consultant for inbios and sanofi-pasteur and is on the scientific advisory boards of moderna and ovagene, and j.e.c. has served as a consultant for takeda vaccines, sanofi pasteur, pfizer, and novavax, is on the scientific advisory boards of compuvax, gigagen, meissa vaccines, […]


Development of Zika Virus Vaccines

PMCID: 5874648
PMID: 29346287
DOI: 10.3390/vaccines6010007

[…] wild-type and mutant sequences to be incorporated. in particular, the nucleoside-modified mrna-lnp vaccines elicit rapid and durable immune protection and represent promising vaccine candidates. moderna therapeutics is currently sponsoring a phase 1 clinical trial of their mrna-1235 zikv vaccine to assess its safety, tolerability, and immunogenicity in healthy adults (, nct03014089)., […]


Dengue virus reactive CD8+ T cells mediate cross protection against subsequent Zika virus challenge

PMCID: 5682281
PMID: 29129917
DOI: 10.1038/s41467-017-01669-z

[…] the manuscript. m.s.d. and s.s. edited the paper., the authors declare that m.s.d. is a consultant for inbios, visterra, aviana, and takeda pharmaceuticals and on the scientific advisory boards of moderna and ovagene. the remaining authors declare no competing financial […]

Want to access the full list of citations?
ModeRNA institution(s)
Faculty of Biology, Adam Mickiewicz University, Poznan, Poland

ModeRNA reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review ModeRNA